Xtx Topco LTD Aclaris Therapeutics, Inc. Transaction History
Xtx Topco LTD
- $1.13 Billion
- Q4 2024
A detailed history of Xtx Topco LTD transactions in Aclaris Therapeutics, Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 44,685 shares of ACRS stock, worth $69,261. This represents 0.01% of its overall portfolio holdings.
Number of Shares
44,685Holding current value
$69,261% of portfolio
0.01%Shares
5 transactions
Others Institutions Holding ACRS
# of Institutions
106Shares Held
87.8MCall Options Held
293KPut Options Held
124K-
Bml Capital Management, LLC Zionsville, IN14.3MShares$22.1 Million21.95% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA9.63MShares$14.9 Million0.04% of portfolio
-
Vivo Capital, LLC Palo Alto, CA8.89MShares$13.8 Million4.3% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD6.2MShares$9.62 Million0.61% of portfolio
-
Ra Capital Management, L.P. Boston, MA4.67MShares$7.23 Million0.19% of portfolio
About Aclaris Therapeutics, Inc.
- Ticker ACRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 66,671,800
- Market Cap $103M
- Description
- Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...